Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassandra L R van Doorn

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|December 13, 2021
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease <i>Mycobacterium tuberculosis</i> Survival in Human MacrophagesCassandra L R van Doorn, Sanne A M Steenbergen, Kimberley V Walburg, et al.
Frontiers in Immunology|September 23, 2021
Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of <i>Salmonella enterica</i> Serovar Typhimurium Infection in Human MacrophagesCassandra L R van Doorn, Gina K Schouten, Suzanne van Veen, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2024
Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant <i>Staphylococcus aureus</i>Robin H G A van den Biggelaar, Kimberley V Walburg, Susan J F van den Eeden, et al.
Scientific Reports|July 26, 2024
Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteriaRobin H G A van den Biggelaar, Kimberley V Walburg, Susan J F van den Eeden, et al.
Ebiomedicine|July 16, 2022
Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatmentCassandra L R van Doorn, Clare Eckold, Katharina Ronacher, et al.
Clinical and Translational Medicine|August 31, 2023
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidityClare Eckold, Cassandra L R van Doorn, Rovina Ruslami, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|December 13, 2021
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease <i>Mycobacterium tuberculosis</i> Survival in Human MacrophagesCassandra L R van Doorn, Sanne A M Steenbergen, Kimberley V Walburg, et al.
Frontiers in Immunology|September 23, 2021
Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of <i>Salmonella enterica</i> Serovar Typhimurium Infection in Human MacrophagesCassandra L R van Doorn, Gina K Schouten, Suzanne van Veen, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2024
Identification of kinase modulators as host-directed therapeutics against intracellular methicillin-resistant <i>Staphylococcus aureus</i>Robin H G A van den Biggelaar, Kimberley V Walburg, Susan J F van den Eeden, et al.
Scientific Reports|July 26, 2024
Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteriaRobin H G A van den Biggelaar, Kimberley V Walburg, Susan J F van den Eeden, et al.
Ebiomedicine|July 16, 2022
Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatmentCassandra L R van Doorn, Clare Eckold, Katharina Ronacher, et al.
Clinical and Translational Medicine|August 31, 2023
Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidityClare Eckold, Cassandra L R van Doorn, Rovina Ruslami, et al.
Pageof 1